Testing for ovarian cancer: updated position statement released

There is no evidence to support the use of any screening test, including pelvic examination, CA125 or other biomarkers, ultrasound, or combination of tests, to look for ovarian cancer in women who are asymptomatic, according to Cancer Australia’s updated position statement Testing for Ovarian Cancer in Asymptomatic Women.

This also applies to surveillance tests for women at high risk or potentially high risk of ovarian cancer who have no symptoms. The statement recommends that referral for genetic assessment should be discussed with women who are at potentially high risk of ovarian cancer, and the most effective risk-reducing strategy for ovarian cancer in women at high risk is bilateral salpingo-oophorectomy. In 2019 an estimated 1510 new cases of ovarian cancer will be diagnosed in Australia and there will be 1046 deaths from this cancer, says Cancer Australia.

WHO launches app to detect hearing loss

A free application for mobile devices that allows people to regularly check their hearing has been developed and launched by the WHO. The app ‘hearWHO’ is targeted at those at risk of, or those who already experience some of the symptoms related to, hearing loss and is especially recommended, by WHO, for those who often listen to loud music over personal audio devices. The app, compatible on iOS and android devices, is based on validated digits-in-noise technology. Users listen and enter a series of three numbers when prompted. The numbers have been recorded against varying levels of background sound, simulating listening conditions in everyday life. The app displays the user’s results and keeps a personalised track record of their hearing status over time. For more information visit www.who.int/deafness/hearWHO/en.